Alfasigma is passion for science
Scientific research is one of the engines of development for Alfasigma. Research targeted at growth and continuous innovation, for which Alfasigma invests the resources required to remain in step with a world that changes rapidly and is increasingly globalised in a sector, that of pharmaceuticals, that is evolving extremely rapidly. In line with its tradition, the work of research and development in Alfasigma’s historic bases in Bologna and Pomezia has resulted, over the years, in molecules such as rifaximin, carnitine, sulodexide and parnapatin gaining full acknowledgement by the international scientific community.
No less important for Alfasigma is biotechnological research, in particular in experimenting with new systems of transport of oncological medicines with the aim of ensuring their effectiveness at the target sites, at the same time minimising any collateral effects on the patient.